AssetMark Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.6M | Sell |
732,448
-25,722
| -3% | -$673K | 0.03% | 383 |
|
|
2026
Q1 | $21.3M | Sell |
758,170
-1,755,145
| -70% | -$46.7M | 0.04% | 321 |
|
|
2025
Q4 | $62.6M | Buy |
2,513,315
+84,848
| +3% | +$2.14M | 0.13% | 135 |
|
|
2025
Q3 | $61.9M | Buy |
2,428,467
+193,859
| +9% | +$4.78M | 0.13% | 138 |
|
|
2025
Q2 | $54.2M | Buy |
2,234,608
+195,624
| +10% | +$4.56M | 0.13% | 141 |
|
|
2025
Q1 | $51.7M | Sell |
2,038,984
-1,614,128
| -44% | -$42.2M | 0.14% | 137 |
|
|
2024
Q4 | $96.9M | Sell |
3,653,112
-46,151
| -1% | -$1.25M | 0.26% | 67 |
|
|
2024
Q3 | $107M | Buy |
3,699,263
+103,548
| +3% | +$3.02M | 0.31% | 64 |
|
|
2024
Q2 | $101M | Buy |
3,595,715
+124,574
| +4% | +$3.43M | 0.31% | 62 |
|
|
2024
Q1 | $96.3M | Sell |
3,471,141
-674,601
| -16% | -$18.7M | 0.31% | 69 |
|
|
2023
Q4 | $119M | Sell |
4,145,742
-838,495
| -17% | -$25.3M | 0.43% | 50 |
|
|
2023
Q3 | $165M | Sell |
4,984,237
-81,335
| -2% | -$2.88M | 0.66% | 36 |
|
|
2023
Q2 | $186M | Buy |
5,065,572
+34,851
| +0.7% | +$1.36M | 0.73% | 34 |
|
|
2023
Q1 | $205M | Buy |
5,030,721
+1,110,210
| +28% | +$48M | 0.85% | 28 |
|
|
2022
Q4 | $201M | Buy |
3,920,511
+91,217
| +2% | +$4.37M | 0.87% | 28 |
|
|
2022
Q3 | $168M | Buy |
3,829,294
+506,338
| +15% | +$24.6M | 0.78% | 34 |
|
|
2022
Q2 | $174M | Buy |
3,322,956
+43,643
| +1% | +$2.22M | 0.78% | 32 |
|
|
2022
Q1 | $170M | Buy |
3,279,313
+117,967
| +4% | +$6.12M | 0.71% | 36 |
|
|
2021
Q4 | $187M | Buy |
3,161,346
+699,270
| +28% | +$34.6M | 0.77% | 32 |
|
|
2021
Q3 | $106M | Sell |
2,462,076
-31,926
| -1% | -$1.41M | 0.47% | 53 |
|
|
2021
Q2 | $97.7M | Buy |
2,494,002
+34,962
| +1% | +$1.36M | 0.45% | 51 |
|
|
2021
Q1 | $89.1M | Buy |
2,459,040
+166,206
| +7% | +$5.9M | 0.46% | 53 |
|
|
2020
Q4 | $84.4M | Buy |
2,292,834
+108,880
| +5% | +$3.99M | 0.47% | 55 |
|
|
2020
Q3 | $76M | Buy |
2,183,954
+166,031
| +8% | +$5.82M | 0.49% | 53 |
|
|
2020
Q2 | $64.4M | Buy |
2,017,923
+435,303
| +28% | +$14.8M | 0.46% | 53 |
|
|
2020
Q1 | $49M | Buy |
1,582,620
+1,326,695
| +518% | +$45.2M | 0.42% | 64 |
|
|
2019
Q4 | $9.51M | Buy |
255,925
+183,932
| +255% | +$6.55M | 0.07% | 202 |
|
|
2019
Q3 | $2.45M | Buy |
71,993
+31
| +0% | +$1.13K | 0.02% | 270 |
|
|
2019
Q2 | $2.96M | Sell |
71,962
-797,920
| -92% | -$31.7M | 0.02% | 250 |
|
|
2019
Q1 | $35.1M | Buy |
869,882
+141,835
| +19% | +$5.68M | 0.32% | 87 |
|
|
2018
Q4 | $30.2M | Buy |
728,047
+679,292
| +1,393% | +$28.2M | 0.29% | 83 |
|
|
2018
Q3 | $2.04M | Sell |
48,755
-3
| -0% | -$115 | 0.02% | 270 |
|
|
2018
Q2 | $1.68M | Sell |
48,758
-2,498
| -5% | -$85.4K | 0.02% | 275 |
|
|
2018
Q1 | $1.73M | Sell |
51,256
-27,177
| -35% | -$934K | 0.02% | 271 |
|
|
2017
Q4 | $2.69M | Buy |
78,433
+31,937
| +69% | +$1.09M | 0.03% | 242 |
|
|
2017
Q3 | $1.57M | Sell |
46,496
-47,871
| -51% | -$1.54M | 0.02% | 263 |
|
|
2017
Q2 | $3.01M | Buy |
94,367
+14,187
| +18% | +$447K | 0.04% | 222 |
|
|
2017
Q1 | $2.6M | Buy |
80,180
+42,058
| +110% | +$1.33M | 0.03% | 229 |
|
|
2016
Q4 | $1.17M | Sell |
38,122
-1,845
| -5% | -$56.3K | 0.02% | 254 |
|
|
2016
Q3 | $1.28M | Buy |
39,967
+2,336
| +6% | +$78.1K | 0.02% | 241 |
|
|
2016
Q2 | $1.26M | Buy |
37,631
+10,907
| +41% | +$348K | 0.02% | 244 |
|
|
2016
Q1 | $752K | Sell |
26,724
-35,955
| -57% | -$1.03M | 0.01% | 294 |
|
|
2015
Q4 | $1.92M | Buy |
62,679
+44,900
| +253% | +$1.41M | 0.04% | 218 |
|
|
2015
Q3 | $530K | Sell |
17,779
-4,227
| -19% | -$136K | 0.01% | 285 |
|
|
2015
Q2 | $700K | Sell |
22,006
-25,543
| -54% | -$832K | 0.01% | 344 |
|
|
2015
Q1 | $1.57M | Sell |
47,549
-31,432
| -40% | -$999K | 0.03% | 228 |
|
|
2014
Q4 | $2.33M | Sell |
78,981
-4,641
| -6% | -$133K | 0.05% | 180 |
|
|
2014
Q3 | $2.35M | Buy |
83,622
+9,298
| +13% | +$261K | 0.05% | 169 |
|
|
2014
Q2 | $2.09M | Buy |
74,324
+53,730
| +261% | +$1.53M | 0.04% | 195 |
|
|
2014
Q1 | $628K | Sell |
20,594
-665
| -3% | -$19.8K | 0.02% | 297 |
|
|
2013
Q4 | $618K | Sell |
21,259
-129,538
| -86% | -$3.77M | 0.01% | 310 |
|
|
2013
Q3 | $4.11M | Buy |
+150,797
| New | +$4.1M | 0.1% | 112 |
|
Other funds holding PFE
AIM
SLAM
CWP
AssetMark Inc's PFE Position: Q2 2026 in Review
AssetMark Inc reduced its Pfizer (PFE) stake by 3.4% in Q2 2026, selling an estimated $673K and leaving 732,448 shares worth $17.6M. The position accounts for 0.03% of the portfolio, ranked #383.
AssetMark Inc first reported a position in PFE in Q3 2013 and has held it in 52 quarters since. The position peaked at $205M in Q1 2023. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- AssetMark Inc held 732,448 shares of Pfizer worth $17.6M as of Q2 2026.
- AssetMark Inc sold 25,722 Pfizer shares in Q2 2026, an estimated $673K.
- Pfizer made up 0.03% of AssetMark Inc's portfolio in Q2 2026, its #383 holding.
- AssetMark Inc first reported a position in Pfizer in Q3 2013 and has held it in 52 quarters since.
- AssetMark Inc's Pfizer position peaked at $205M in Q1 2023.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.